Every advancement in curing childhood cancer is the result of research.
Researchers at the Aflac Cancer Center and Blood Disorders Service of Children’s Healthcare of Atlanta seek answers to pediatric oncologic and hematologic conditions with two goals: discovery and integration. Through translational research, the Aflac Cancer Center provides leading-edge care to children and young adults with cancer and blood disorders while creating an innovative environment for physicians and researchers.
Research Areas of Focus
|
|
|
|
|
|
Visit our online clinical trials database.
This tools allows you to search and view our open clinical trials. For each trial, you will find a brief summary, objectives and eligibility criteria.
|
|
|
|
|
|
Learn more
- Types of research
The Aflac Cancer Center conducts lab research that focuses on gene therapy, molecular therapy, cell signaling, nanomedicine and genomics. Learn about the four different types of research, including: epidemiology, basic research, translational research and clinical trials.
- Clinical trials
The Aflac Cancer Center is home of one of the largest pediatric clinical trial programs in the country—offering our patients access to some of the most novel treatment options in the country. Learn about the the different phases of clinical trials, who can participate and the benefits of participating.
- Our goals
The Aflac Cancer Center is committed to excellence and innovation in pediatric cancer and blood disorders research. Read about how we continue to expand our research program.
- Highlights and accomplishments
The Aflac Cancer Center is one of only 3 centers in the Southeast that is a member of the Children's Oncology Group (COG) Phase I Consortium. Read about our other highlights and accomplishments.
- Research collaborations
At the Aflac Cancer Center, there is a significant opportunity to advance research and teaching in pediatric cancer and blood disorders. Learn how the we are uniquely positioned to leverage the vast capabilities in Atlanta.
- News and articles
The Center for Pediatric Nanomedicine (CPN) is the first of its kind in the world. Read other recent news stories and articles.